Description
This variant disrupts the p.Pro418 amino acid residue in SH3BP2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17321449, 18596838, 28644570, 23298620, 11381256). This suggests that this residue is clinically-significant, and that variants that disrupt this residue are likely to be disease-causing. This variant has been reported to affect SH3BP2 protein function (PMID: 22153077). This variant has been observed in individuals and families affected with cherubism (PMID: 11381256, 27272835, 23298620). ClinVar contains an entry for this variant (Variation ID: 7547). This variant is not present in population databases (ExAC no frequency). This sequence change replaces proline with leucine at codon 418 of the SH3BP2 protein (p.Pro418Leu). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and leucine. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
# | Sample | Method | Observation |
---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences |
---|
1 | germline | unknown | not provided | not provided | not provided | | not provided | not provided | not provided | not provided |